OCULAR THERAPEUTIX, INC.

(OCUL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about OCULAR THERAPEUTIX, INC.
05/11Berenberg Bank Cuts Price Target on Ocular Therapeutix to $21 From $23, Maintains Buy R..
MT
05/10Ocular therapeutix reports first quarter 2022 financial results and business update
AQ
05/10HC Wainwright Adjusts Price Target on Ocular Therapeutix to $10 From $14, Reiterates Bu..
MT
05/10Piper Sandler Adjusts Price Target on Ocular Therapeutix to $16 From $20, Reiterates Ov..
MT
05/09OCULAR THERAPEUTIX : Q1 Earnings Snapshot
AQ
05/09TRANSCRIPT : Ocular Therapeutix, Inc., Q1 2022 Earnings Call, May 09, 2022
CI
05/09Earnings Flash (OCUL) OCULAR THERAPEUTIX Posts Q1 Revenue $13.2M, vs. Street Est of $13..
MT
05/09Ocular Therapeutix, Inc. Reports Earnings Results for the First Quarter Ended March 31,..
CI
05/09Ocular Therapeutix™ Reports First Quarter 2022 Financial Results and Business Upd..
BU
05/09Ocular Therapeutix, Inc. Provides Earnings Guidance for the Full Year 2022
CI
05/04Ocular therapeutix to present pre-clinical data at the american society of gene & cell ..
AQ
05/03Ocular Therapeutix™ To Present Pre-Clinical Data at the American Society of Gene ..
BU
04/27Ocular therapeutix to report first quarter 2022 financial results
AQ
04/26Ocular therapeutix to present pre-clinical and clinical data at the 2022 association fo..
AQ
04/26Ocular Therapeutix™ to Report First Quarter 2022 Financial Results
BU
More most relevant news
All news about OCULAR THERAPEUTIX, INC.
05/11Berenberg Bank Cuts Price Target on Ocular Therapeutix to $21 From $23, Maintains Buy R..
MT
05/10Ocular therapeutix reports first quarter 2022 financial results and business update
AQ
05/10HC Wainwright Adjusts Price Target on Ocular Therapeutix to $10 From $14, Reiterates Bu..
MT
05/10Piper Sandler Adjusts Price Target on Ocular Therapeutix to $16 From $20, Reiterates Ov..
MT
05/09OCULAR THERAPEUTIX : Q1 Earnings Snapshot
AQ
05/09TRANSCRIPT : Ocular Therapeutix, Inc., Q1 2022 Earnings Call, May 09, 2022
CI
05/09OCULAR THERAPEUTIX, INC Management's Discussion and Analysis of Financial Condition an..
AQ
05/09Earnings Flash (OCUL) OCULAR THERAPEUTIX Posts Q1 Revenue $13.2M, vs. Street Est of $13..
MT
05/09Ocular Therapeutix, Inc. Reports Earnings Results for the First Quarter Ended March 31,..
CI
05/09Ocular Therapeutix™ Reports First Quarter 2022 Financial Results and Business Upd..
BU
More news
News in other languages on OCULAR THERAPEUTIX, INC.
05/09Earnings Flash (OCUL) OCULAR THERAPEUTIX affiche un revenu de 13,2 M$ au 1er trimestre,..
05/09Ocular Therapeutix, Inc. annonce ses résultats pour le premier trimestre clos le 31 mar..
05/09Ocular Therapeutix, Inc. Fournit des prévisions de bénéfices pour l'année 2022 complète
02/28Ocular Therapeutix, Inc. annonce ses résultats pour l'année complète se terminant le 31..
02/28Ocular Therapeutix, Inc. annonce ses résultats pour le quatrième trimestre clos le 31 d..
02/28Earnings Flash (OCUL) OCULAR THERAPEUTIX affiche un chiffre d'affaires de 12,3 millions..
02/28HISTORIQUE DES RÉACTIONS AUX BÉNÉFIC : Ocular Therapeutix Inc, indicateur de suivi à 40,0%..
02/07Ocular Therapeutix, Inc. annonce la démission de Bruce A. Peacock en tant que membre du..
01/18Ocular Therapeutix déclare qu'AffaMed a administré la dose au premier patient de l'essa..
2021Ocular Therapeutix affirme que l'insert intracanaliculaire soulage les symptômes de la ..
More news
Analyst Recommendations on OCULAR THERAPEUTIX, INC.
05/11Berenberg Bank Cuts Price Target on Ocular Therapeutix to $21 From $23, Maintains Buy R..
MT
05/10HC Wainwright Adjusts Price Target on Ocular Therapeutix to $10 From $14, Reiterates Bu..
MT
05/10Piper Sandler Adjusts Price Target on Ocular Therapeutix to $16 From $20, Reiterates Ov..
MT
03/01JMP Securities Adjusts Ocular Therapeutix's Price Target to $22 from $30, Keeps Market ..
MT
2021Berenberg Bank Adjusts Price Target on Ocular Therapeutix to $23 From $26, Maintains Bu..
MT
More recommendations
Press releases
05/10Ocular therapeutix reports first quarter 2022 financial results and business update
AQ
05/09OCULAR THERAPEUTIX : Q1 Earnings Snapshot
AQ
05/09OCULAR THERAPEUTIX, INC Management's Discussion and Analysis of Financial Condition an..
AQ
05/09Ocular Therapeutix™ Reports First Quarter 2022 Financial Results and Business Upd..
BU
05/04Ocular therapeutix to present pre-clinical data at the american society of gene & cell ..
AQ
More press releases